Getein Biotech (SHSE:603387) Marketable Securities : ¥518 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Getein Biotech's Marketable Securities for the quarter that ended in Mar. 2024 was ¥518 Mil.

Getein Biotech's annual Marketable Securities declined from Dec. 2021 (¥613 Mil) to Dec. 2022 (¥511 Mil) and declined from Dec. 2022 (¥511 Mil) to Dec. 2023 (¥452 Mil).

Getein Biotech Marketable Securities Historical Data

The historical data trend for Getein Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Marketable Securities Chart

Getein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

467.36

594.92

612.68

511.14

451.91

Getein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															369.41	391.13	534.57	451.91	518.50

Getein Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Getein Biotech (SHSE:603387) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Getein Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Getein Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines